氣相層析法-市場佔有率分析、產業趨勢與統計、2024 年至 2029 年成長預測

主要亮點

• 氣相層析法市場預計在預測期內複合年成長率為 5.6%
• 由於診斷中心和研究機構的關閉，2020 年初 COVID-19 的爆發阻礙了氣相層析法市場的發展。然而，在大流行的後期，即2021年，由於目標人群呼吸系統疾病的發病率增加，全球範圍內將無法獲得診斷冠狀病毒後綜合症（PCS）和相關併發症的可靠技術。由於其即時護理優勢，分析量有所增加。根據 2022 年 3 月發表在《分析與生物分析化學雜誌》上的一項研究，在大流行期間可以使用多種技術進行呼吸分析，包括氣相層析法(GC) 和氣相層析法-質譜法(GC- MS)。
• 此外，根據上述資訊來源，GC-MS在疫情期間被廣泛採用，可以對個體進行分子鑑定。因此，根據市場狀況分析，GC和GC-MS的需求在後期，即從2021年開始增加，這對所研究的市場成長產生了正面影響。此外，隨著 SARS-CoV-2 病毒變種和相關併發症案例數量的增加，GC 的需求預計將增加，並有望在預測期內促進市場成長。
• 推動市場成長的因素包括層析法測試在醫藥品認證過程中的重要性日益增加以及 GC-MS 在疾病檢測中的日益採用。
• 氣相層析法(GC) 作為分離、定量和鑑定藥物分析物（尤其是低濃度藥物分析物）的強大分析技術之一，在科學和法律領域被廣泛接受。根據 Sigma-Aldrich Solutions 2023 年 1 月的更新，GC 通常用於分離和分析混合物中的揮發性和半揮發性化合物，如呼氣、血液、唾液和其他分泌物。它是一種分析技術。它也是一種流行的分析技術，結合了出色的分離能力、速度和靈敏度。此外，各種資訊來源表明，GC 由於其能夠提供精確分離能力、重現性和快速分離等優異特性，因此在分析化學中具有深入的應用。 GC廣泛應用於藥品、化妝品、環境毒素等各領域。因此，由於這些優勢和好處，GC 的需求正在增加，預計將在預測期內推動市場成長。
• 此外，GC 可用於對微生物進行化學表徵。因此，它被用於各種感染疾病的檢測。也可用於多種發炎疾病的精準檢測。根據Research Square 2022年5月發表的研究，呼出的氣體來自吸入的空氣中源自外部環境的物質和體內產生的物質，可檢測和分析極微量的1000多種最終代謝物約為十億分之一。呼吸氣體分析是一種非常有用的連續監測技術，因為它是非侵入性的，並且可以記錄隨時間的變化。 GC-MS 技術的最新發展使揮發性有機化合物的分析取得了許多進展。因此，GC-MS 在此類研究和分析平台中的應用預計將推動整體市場的成長。
• 此外，研究市場的技術進步以及主要市場參與者的新產品發佈、合作夥伴關係和其他戰略舉措將推動市場發展。 例如，2022 年 6 月，安捷倫科技公司推出了幾款新型 LC/MS 和 GC/MS 四極桿質譜儀。 這些新產品提高了內置儀器智慧的標準，通過更高水準的儀器診斷最大限度地延長了系統正常運行時間，實現了日常維護的主動調度，並通過允許操作員專注於分析而不是設備來最大限度地減少對實驗室生產力的影響。 預計此類技術創新將在預測期內推動氣相色譜市場的增長。
• 然而，氣相層析法設備的高成本和缺乏熟練的專業人員來操作該程序預計將阻礙市場的成長。

氣相層析法(GC) 市場趨勢

預計製藥和生物產業將在預測期內佔據主要市場佔有率

• 根據樣品中層析法的類型，與適當的檢測器結合使用時，氣相層析法可應用於製藥和生物製藥行業的定性和定量分析。
• 在製藥業中使用氣相層析的主要原因是其高分離效率、檢測少量分離物質的高檢測靈敏度以及對非常複雜的混合物進行定量分析所獲得的資料的準確性和準確度。此外，GC 分析從樣品引入到分離都是自動化的，使其無憂無慮。根據 DPS Instruments Europe GmbH 的 2023 年更新，可以使用該公司提供的 600 系列實驗室 GC 的自訂GC 配置之一來分析各種製藥應用。此外，如上述來源所述，使用這些 GC 系統，無論分析是在實驗室、工廠或現場進行，藥物結果都保持一致。
• 此外，GC-MS 可用於血液和尿液的生物分析，以檢測是否存在巴比妥類藥物、酒精、麻醉劑、殘留溶劑、麻醉劑、抗組織胺、抗驚厥藥、鎮靜催眠藥和專門用於食品的藥物。毒素和毒物也可以使用 GC-MS 來鑑定。 GC-MS 也廣泛應用於臨床毒理學。例如，2022 年 2 月在 NCBI 發表的一項研究表明，結合 GC 和漂移管離子離子移動率譜 (IMS) 可以產生小於 8.4% 的相對誤差，從而可以檢測口腔液中的烈酒。以及測定活性物質的靈敏方法。因此，由於上述主要優點和可靠的結果，氣相層析法被廣泛用於製藥和生物技術行業的品管目的。因此，預計上述因素將在預測期內推動該領域的成長。

預計北美在預測期內將佔據主要市場佔有率

• 預計在預測期內，北美將佔據氣相層析法市場的重要佔有率。這是由於擴大採用氣相層析技術以及製藥和生物製藥領域的研究不斷增加。層析法設備也被證明是最終生產測試、製藥應用、環境監測、食品測試等領域的有效技術。推動該地區市場成長的其他因素包括慢性病盛行率上升、對藥物研發的需求不斷成長以及對個人化藥物的需求不斷成長。
• 對用於發現高度複雜藥物的改進和新穎藥物評價技術的研究和開發（R&D）的日益關注，在該地區新層析法方法的發展中發揮了重要作用。Masu。例如，2022 年 6 月，Focused Photonics, Inc. 推出了一款工業線上氣相層析法分析儀，在傳統實驗室層析法中脫穎而出。本裝置採用高精度程控管柱切割技術及管柱系統採樣技術，可快速分析採集被測成分。這些新興市場的開拓預計將推動該地區的市場成長。
• 此外，層析法技術的日益普及，特別是在食品和飲料和製藥行業，也推動了該地區對氣相層析的需求。嚴重的增加正在增加製藥業對藥物藥物研發和製造的研發投資，進一步增加了北美對層析法技術的需求。例如，根據美國藥物研究和製造商（PhRMA）產業組織更新的資料，2021年會員企業的研發費用達到近79,610美元，高於上年度的72,412美元。美國如此高的藥品支出預計將有助於美國的新藥發現，並推動藥物研發應用中對氣相層析的需求。預計這將推動該國市場的成長，並推動預測期內整體研究市場的成長。

氣相層析法(GC) 產業概述

氣相層析法市場競爭激烈，由大量公司組成。

Agilent Technologies Inc.、Chromatotec、Restek Corporation、Danaher Corporation、Merck KgaA、Teledyne Technologies、PerkinElmer Inc.、Scion Instruments、Shimadzu Corporation 和 Thermo Fisher Scientific Inc. 等公司在氣相層析法市場佔有主要佔有率。大公司最近採取了許多策略舉措來增加其在市場上的影響力。

其他福利

• Excel 格式的市場預測 (ME) 表
• 3 個月分析師支持

目錄

第1章簡介

• 研究假設和市場定義
• 調查範圍

第2章研究方法

第3章執行摘要

第4章市場動態

• 市場概況
• 市場促進因素
  • 層析法測試在醫藥品認證過程中的重要性日益增加
  • 擴大採用氣相層析法質譜法 (GC-MS)
• 市場阻礙因素
  • 氣相層析法設備高成本
  • 缺乏熟練的專業人員
• 波特五力分析
  • 新進入者的威脅
  • 買家/消費者的議價能力
  • 供應商議價能力
  • 替代產品的威脅
  • 競爭強度

第5章市場區隔（市場規模）

• 依產品
  • 系統
  • 檢測器
  • 自動取樣器
  • 分液收集器
  • 其他產品
• 依最終用戶
  • 醫藥及生物製藥產業
  • 學術研究所
  • 其他最終用戶
• 依地區
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 中東/非洲
    • GCC
    • 南非
    • 其他中東/非洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區

第6章 競爭環境

• 公司簡介
  • Agilent Technologies Inc.
  • Chromatotec
  • Danaher Corporation
  • Teledyne Technologies
  • Merck KgaA
  • PerkinElmer Inc.
  • Restek Corporation
  • Scion Instruments
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Air Liquide
  • Process Sensing Technologies（LDetek Inc.）
  • Hobre Instruments BV
  • Waters Corporation
  • Sartorius

第7章 市場機會及未來趨勢

Key Highlights

• The gas chromatography market is expected to witness a CAGR of 5.6% during the forecast period.
• The onset of COVID-19 hampered the market for gas chromatography in the initial days of 2020 due to the closure of diagnostic centers and research institutes. However, during the later phases of the pandemic, or in 2021due to higher incidences of breathing incidents among the target population, an urgent need to have reliable technologies to diagnose post-coronavirus disease syndrome (PCS) and related complications increased worldwide, as demand for breath-analysis was increased due to the point-of-care benefits of the process. According to a study published in the Journal of Analytical and Bioanalytical Chemistry in March 2022, different methods were available for breath analysis during the pandemic, including gas chromatography (GC) and gas chromatography-mass spectrometry (GC-MS), among other technologies.
• In addition, as per the source above, GC-MS was adopted widely during the pandemic, which provided individual molecular identification. Thus, as per the analysis, the demand for GC and GC-MS increased during the later phases, that is, during 2021 or further, and it positively impacted the studied market growth. Further, with growing instances of the number of variants of the SARS-CoV-2 virus and related complications, the demand for GC is anticipated to increase and is expected to contribute to the market growth during the forecast period.
• The factors driving the market growth include the growing importance of chromatography tests in the drug approval process and the rising adoption of GC-MS for disease detection.
• Gas chromatography (GC) is widely accepted in both scientific and legal arenas as one of the powerful analytical techniques for the separation, quantification, and identification of drug analytes, especially at low levels of concentration. As per the January 2023 update by Sigma-Aldrich Solutions, GC is a common analytical technique used to separate and analyze volatile and semi-volatile compounds such as exhaled human breath, blood, saliva, and other secretions in a mixture. Also, it is a popular analytical technique that combines exceptional resolving power with speed and sensitivity. In addition, various sources have suggested that GC has a profound use in analytical chemistry, owing to its ability to offer excellent features, like accurate separation capabilities, reproducibility, and quicker separation. GC is used extensively in different fields, such as pharmaceuticals, cosmetics, and environmental toxins. Thus, owing to such advantages and benefits, the demand for GC is increasing and is predicted to fuel the growth of the market during the forecast period.
• Additionally, the GC can be used to characterize microorganisms chemically. Hence, it is used for the detection of various infectious diseases. Also, it can be used for the fine detection of various inflammatory diseases. As per a research study published in the Research Square journal in May 2022, exhaled gas is derived from substances in inhaled air originating from the external environment and from substances produced in the body, and this exhaled gas can be analyzed with nearly 1,000 end-metabolites or more being detected in extremely small amounts on the order of parts per billion by GC-MS. As exhaled gas analysis is non-invasive and can record changes over time, it is a very helpful technique for continuous monitoring. Much progress has been made in the analysis of volatile organic compounds thanks to recent developments in GC-MS technology. Thus, the application of GC-MS in such research and analytical platforms is anticipated to fuel the overall market growth.
• Moreover, technological advancements in the studied market with new product launches, partnerships, and other strategic initiatives by key market players will boost the market. For instance, in June 2022, Agilent Technologies launched several new LC/MS and GC/MS quadrupole mass spectrometers, which are raising the level of built-in instrument intelligence and a higher level of instrument diagnostics to maximize system uptime, allowing proactive scheduling of routine maintenance, and minimizes the impact on lab productivity by allowing operators to focus on their analyses rather than on their instruments. Such innovations are expected to propel the gas chromatography market growth over the forecast period.
• However, the high cost of gas chromatography equipment and a lack of skilled professionals to operate the procedures are expected to hinder the market's growth.

Gas Chromatography (GC) Market Trends

Pharmaceutical and Bioindustries is Expected to Hold a Significant Market Share Over the Forecast Period

• In combination with proper detectors selective to the type of analyte in the sample, gas chromatography finds application in qualitative and quantitative analysis in the pharmaceutical and biopharmaceutical industry.
• The high efficiencies of separation power, the extreme detection sensitivity while detecting small amounts of separated species, and the accuracy and precision of the data from quantitative analyses of extremely complex mixtures are the major reasons why GC is used in the pharmaceutical industry. GC analyses are also less hassle-free while automating from sample introduction to separation. As per the 2023 update by DPS Instruments Europe GmbH, various pharmaceutical Applications can be analyzed using one of the Custom GC configurations of the Series 600 Lab GC offered by the company. In addition, as per the source above, whether the analysis is done in the Lab, in the factory, or out in the field, with the use of these GC systems, pharmaceutical results remain consistent.
• In addition, GC-MS is exclusively used in the bio-analysis of blood and urine for the presence of barbiturates, alcohols, narcotics, residual solvents, drugs like anesthetics, antihistamines, anticonvulsants, and anti-epileptic drugs, sedative-hypnotics, and food items. Toxins and venoms can also be identified by GC-MS. It is extensively used in clinical toxicology as well. For instance, according to a study published in NCBI in February 2022, a GC coupled with a drift tube ion mobility spectrometer (IMS) can obtain relative percentage errors lower than 8.4% and can be a reliable, selective, and sensitive technique for the determination of psychoactive substances in oral fluids. Therefore, as a result of the aforementioned main advantages and reliable results, GC is extensively used for quality control purposes in the pharmaceutical and biotechnology industries. Hence, the above-mentioned factors are anticipated to fuel the segment's growth over the forecast period.

North America is Expected to Hold a Significant Share of the Market During the Forecast Period

• North America is expected to hold a major share of the gas chromatography market during the forecast period, owing to the increasing adoption of GC techniques and increasing research in the pharmaceutical and biopharmaceutical sectors. In addition, chromatography instrumentation has proven to be an effective technology for final production testing, pharmaceutical applications, environmental monitoring, and food testing, among others. Other factors propelling the growth of the market in the region include the rising prevalence of chronic diseases coupled with the increasing need for drug discovery and the augmented demand for personalized medicines.
• The increasing focus on the research and development (R&D) of improved and novel drug assessment techniques, which have been used to discover highly complex drugs, is playing a vital role in the evolution of new chromatographic methods in the region. For instance, in June 2022, Focussed Photonics, Inc. launched an industrial online gas chromatography analyzer that is distinct from the conventional laboratory setting chromatography. It uses a high-precision program-controlled column-cutting technology and column system sampling technology through which the measured components can be analyzed and obtained swiftly. Such developments are expected to drive the market growth in the region.
• Furthermore, the increased adoption of chromatography techniques, majorly in the food and beverage and pharmaceutical industries, drives the demand for GC in the region. With the rising number of critical diseases, the R&D investments in the pharmaceutical industry for drug discovery and production are increasing, which has further increased the demand for chromatography techniques in North America. For instance, as per the data updated by the Pharmaceutical Research and Manufacturers of America (PhRMA) trade group, in 2021, the R&D expenditure of its member companies reached nearly USD 79,610 2021, which increased from USD 72,412 in the previous year in the country. This high expenditure on pharmaceuticals in the country is expected to contribute to new drug discovery in the United States and propel the demand for GC used for drug discovery applications. This is expected to fuel the market growth in the country and drive the overall growth of the market studied market during the forecast period.

Gas Chromatography (GC) Industry Overview

The gas chromatography market is highly competitive and consists of a number of players. Companies like Agilent Technologies Inc., Chromatotec, Restek Corporation, Danaher Corporation, Merck KgaA, Teledyne Technologies, PerkinElmer Inc., Scion Instruments, Shimadzu Corporation, and Thermo Fisher Scientific Inc., among others, hold substantial market shares in the gas chromatography market. Many strategic initiatives have recently been taken in the market by the major players to strengthen their market presence.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing Importance of Chromatography Tests in the Drug Approval Process
  • 4.2.2 Rising Adoption of Gas Chromatography-Mass Spectroscopy (GC-MS)
• 4.3 Market Restraints
  • 4.3.1 High Cost of Gas Chromatography Equipment
  • 4.3.2 Lack of Skilled Professionals
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - in USD)

• 5.1 By Product
  • 5.1.1 Systems
  • 5.1.2 Detectors
  • 5.1.3 Auto-samplers
  • 5.1.4 Fraction Collectors
  • 5.1.5 Other Products
• 5.2 By End-User
  • 5.2.1 Pharmaceutical and Biopharmaceutical Industries
  • 5.2.2 Academic Research Institutes
  • 5.2.3 Other End-Users
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Agilent Technologies Inc.
  • 6.1.2 Chromatotec
  • 6.1.3 Danaher Corporation
  • 6.1.4 Teledyne Technologies
  • 6.1.5 Merck KgaA
  • 6.1.6 PerkinElmer Inc.
  • 6.1.7 Restek Corporation
  • 6.1.8 Scion Instruments
  • 6.1.9 Shimadzu Corporation
  • 6.1.10 Thermo Fisher Scientific Inc.
  • 6.1.11 Air Liquide
  • 6.1.12 Process Sensing Technologies (LDetek Inc.)
  • 6.1.13 Hobre Instruments BV
  • 6.1.14 Waters Corporation
  • 6.1.15 Sartorius

7 MARKET OPPORTUNITIES AND FUTURE TRENDS